Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Jones

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Bioresource Technology|July 11, 2016
Maximising biohydrogen yields via continuous electrochemical hydrogen removal and carbon dioxide scrubbingJaime Massanet-Nicolau, Rhys Jon Jones, Alan Guwy, et al.
Bioresource Technology|April 22, 2015
Removal and recovery of inhibitory volatile fatty acids from mixed acid fermentations by conventional electrodialysisRhys Jon Jones, Jaime Massanet-Nicolau, Alan Guwy, et al.
Cancer Biology & Therapy|February 13, 2010
Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasisPamela M Holland, Robert Miller, Jon Jones, et al.
The American Journal of the Medical Sciences|March 3, 2010
Association of intravesical tumor location with metastases to the pelvic lymph nodes in transitional cell cancer of the bladderSteffen Alexander Wedel, Jon Jones, Igor Tsaur, et al.
Molecular Medicine Reports|April 12, 2011
CXC chemokine mRNA expression as a potential diagnostic tool in prostate cancerSteffen A Wedel, Ivaylo N Raditchev, Jon Jones, et al.
Experimental Cell Research|August 21, 2007
CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cellsJon Jones, Dana Marian, Eva Weich, et al.
BMC Cancer|May 29, 2009
Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cellsEva Juengel, Johanna Engler, Iyad Natsheh, et al.
Journal of Cellular and Molecular Medicine|September 1, 2007
Transient down-regulation of beta1 integrin subtypes on kidney carcinoma cells is induced by mechanical contact with endothelial cell membranesJon Jones, Stefan Berkhoff, Eva Weich, et al.
Bioresource Technology|September 10, 2023
Production of volatile fatty acids by anaerobic digestion of biowastes: Techno-economic and life cycle assessmentsAriane S S Pinto, Lewis J McDonald, Rhys Jon Jones, et al.
Journal of Cellular and Molecular Medicine|December 11, 2008
Valproic acid blocks adhesion of renal cell carcinoma cells to endothelium and extracellular matrixJon Jones, Eva Juengel, Ausra Mickuckyte, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Bioresource Technology|July 11, 2016
Maximising biohydrogen yields via continuous electrochemical hydrogen removal and carbon dioxide scrubbingJaime Massanet-Nicolau, Rhys Jon Jones, Alan Guwy, et al.
Bioresource Technology|April 22, 2015
Removal and recovery of inhibitory volatile fatty acids from mixed acid fermentations by conventional electrodialysisRhys Jon Jones, Jaime Massanet-Nicolau, Alan Guwy, et al.
Cancer Biology & Therapy|February 13, 2010
Combined therapy with the RANKL inhibitor RANK-Fc and rhApo2L/TRAIL/dulanermin reduces bone lesions and skeletal tumor burden in a model of breast cancer skeletal metastasisPamela M Holland, Robert Miller, Jon Jones, et al.
The American Journal of the Medical Sciences|March 3, 2010
Association of intravesical tumor location with metastases to the pelvic lymph nodes in transitional cell cancer of the bladderSteffen Alexander Wedel, Jon Jones, Igor Tsaur, et al.
Molecular Medicine Reports|April 12, 2011
CXC chemokine mRNA expression as a potential diagnostic tool in prostate cancerSteffen A Wedel, Ivaylo N Raditchev, Jon Jones, et al.
Experimental Cell Research|August 21, 2007
CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cellsJon Jones, Dana Marian, Eva Weich, et al.
BMC Cancer|May 29, 2009
Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cellsEva Juengel, Johanna Engler, Iyad Natsheh, et al.
Journal of Cellular and Molecular Medicine|September 1, 2007
Transient down-regulation of beta1 integrin subtypes on kidney carcinoma cells is induced by mechanical contact with endothelial cell membranesJon Jones, Stefan Berkhoff, Eva Weich, et al.
Bioresource Technology|September 10, 2023
Production of volatile fatty acids by anaerobic digestion of biowastes: Techno-economic and life cycle assessmentsAriane S S Pinto, Lewis J McDonald, Rhys Jon Jones, et al.
Journal of Cellular and Molecular Medicine|December 11, 2008
Valproic acid blocks adhesion of renal cell carcinoma cells to endothelium and extracellular matrixJon Jones, Eva Juengel, Ausra Mickuckyte, et al.
Pageof 6